Randall Fields Sells 2,000 Shares of ReposiTrak (NYSE:TRAK) Stock

ReposiTrak Inc. (NYSE:TRAKGet Free Report) CEO Randall Fields sold 2,000 shares of the business’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $13.47, for a total value of $26,940.00. Following the completion of the sale, the chief executive officer owned 5,000 shares in the company, valued at $67,350. This represents a 28.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

ReposiTrak Price Performance

NYSE:TRAK traded up $0.39 on Friday, reaching $13.73. 92,236 shares of the company’s stock were exchanged, compared to its average volume of 53,687. The firm has a market capitalization of $251.09 million, a price-to-earnings ratio of 39.23 and a beta of 0.39. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.09 and a current ratio of 6.09. The company has a fifty day moving average of $15.45. ReposiTrak Inc. has a 52 week low of $13.04 and a 52 week high of $25.01.

ReposiTrak (NYSE:TRAKGet Free Report) last posted its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. The company had revenue of $5.97 million for the quarter. ReposiTrak had a net margin of 30.55% and a return on equity of 14.25%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. BNP Paribas Financial Markets grew its position in shares of ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after purchasing an additional 634 shares in the last quarter. Ingalls & Snyder LLC boosted its stake in ReposiTrak by 1.3% during the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock valued at $3,905,000 after buying an additional 2,554 shares during the period. Tower Research Capital LLC TRC grew its position in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after buying an additional 2,892 shares in the last quarter. Ellsworth Advisors LLC increased its stake in ReposiTrak by 10.6% in the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock worth $634,000 after acquiring an additional 2,997 shares during the last quarter. Finally, Raymond James Financial Inc. increased its stake in ReposiTrak by 22.5% in the 3rd quarter. Raymond James Financial Inc. now owns 17,359 shares of the company’s stock worth $257,000 after acquiring an additional 3,185 shares during the last quarter. 27.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

TRAK has been the topic of several recent research reports. Wall Street Zen downgraded ReposiTrak from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of ReposiTrak in a research note on Wednesday. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

Read Our Latest Report on ReposiTrak

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Featured Articles

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.